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Abstract 
 
Purpose: To identify variables associated with myopia progression and to identify 
any interaction between accommodative function, myopia progression, age and 
treatment effect in the Cambridge Anti Myopia Study. 
 
Methods: Contact lenses were used to improve static accommodation by altering 
ocular spherical aberration and vision training was performed to improve dynamic 
accommodation. 142 subjects, aged 14-21 years, were recruited who had a 
minimum of -0.75D of myopia. Subjects were assigned to contact lens treatment 
only, vision training only, contact lens treatment and vision training, or control group. 
Spherical aberration, lag of accommodation, accommodative convergence 
/accommodation (AC/A) ratio, accommodative facility, ocular biometry and refractive 
error were measured at regular intervals throughout the two year trial. 
 
Results: Ninety five subjects completed the 24 months trial period. There was no 
significant difference in myopia progression between the four treatment groups at 24 
months.  Age, lag of accommodation and AC/A ratio were significantly associated 
with myopia progression. There was a significant treatment effect at 12 months in the 
contact lens treatment group in younger subjects, based on a median split, aged 
under 16.9 years (p=0.005). This treatment effect was not maintained over the 
second year of the trial. Younger subjects experienced a greater reduction in lag of 
accommodation with the treatment contact lens at 3 months (p=0.03), compared to 
older contact lens treatment and control groups. There was no interaction between 
AC/A ratio and contact lens treatment effect. 
 
Conclusions: Age, lag of accommodation and AC/A ratio were significantly 
associated with myopia progression. Although there was no significant treatment 
effect at 24 months, an interaction between age and contact lens treatment suggests 
younger subjects may be more amenable, at least in the short term, to alteration of 
the visual system using optical treatments.  
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Myopia is common in Caucasian and Asian populations, and its prevalence in some 
populations is on the increase.1-8 In UK based populations, myopia prevalence 
amongst children ranges from 2.8% to 29.4% dependent upon age and ethnicity. 9-11 
Both environmental and genetic factors are likely to be involved in myopia 
development.12 
 
An increased lag of accommodation has been found in both myopic children and 
adults when compared to other refractive groups in some studies13-16 but not in 
others.17-19 Goss20 and Gwiazda et al.21 found that accommodative responses were 
reduced before the onset on myopia, but Mutti et al.22 found the increased lag was 
only present after the onset of myopia, and disputed the idea that an increased lag of 
accommodation caused myopia development. Allen and O’Leary16 found that both an 
increased lag of accommodation and reduced accommodative facility were 
independently correlated with the progression of myopia over the following 12 
months.  
 
Recently the relationship between the treatment effect on the near focus and the 
resultant effect on myopia progression has been investigated by Berntsen et al 23 
who found no significant association between lag of accommodation and myopia 
progression in their cohort aged 6-11 years, where lag of accommodation was 
manipulated using progressive addition lenses in 41 subjects over a 1 year period 
before reverting back to single vision lens wear. Previously the CLEERE study group 
had not found an association between lag of accommodation and annual myopia 
progression in their cohort.24  
 
There is evidence that some types of retinal defocus are related to myopic 
progression. A clinical trial aiming to slow myopic progression using spectacle lenses 
that reduced peripheral hyperopic defocus, rather than foveal hyperopic defocus,  
showed that one of three experimental lens treatments had a small effect that was 
greater in younger subjects with parental myopia.25 Myopia progression is, on 
average, greater in younger children and reduces with age.26 In animal models, 
neonates show an increased response to image degradation when compared to older 
animals.27 
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The Cambridge Anti Myopia Study (CAMS) was designed to improve two 
accommodation functions. Treatment consisted of aberration control contact lenses 
to reduce lag of accommodation and vision training to increase accommodative 
facility. Whilst accommodative function can be improved through vision training28-33 
and manipulation of ocular aberrations34,35 their effects on refractive error progression 
have not yet been established. The main outcome measures of CAMS were 
progression of myopia (assessed by cycloplegic auto-refraction) and axial length 
measurement (assessed by partial coherence interferometry). The treatment design, 
methods and outcome have already been published.36 Overall there was no 
significant treatment effect .This paper assesses the interaction between treatment 
modality and age, on accommodative function and myopia progression, which were 
assessed at each of the follow up visits throughout the 2 year trial period. This paper 
aims to add to existing literature on variables associated with myopia progression. 
 
Methods 
The treatment modality for CAMS employed custom designed contact lenses to alter 
existing ocular spherical aberration, in an attempt to improve static accommodation 
responses during near-work, in conjunction with a vision-training program to improve 
accommodation dynamics. A factorial trial design was used to test the efficacy of the 
two independent treatments simultaneously. The clinical trial received ethical 
approval from the Anglia Ruskin University Research Ethics Committee and complied 
with the tenets of the Declaration of Helsinki.  
 
Study Design 
142 myopic subjects aged 14-22 years were recruited according to the following 
criteria: 
 Spherical equivalent refractive error: -0.75 to –10.00 Dioptres 
 Astigmatism: 0.75 Dioptres or less 
 Zero or positive levels of spherical aberration at distance 
 Corrected log MAR visual acuity: 0.00 or better in each eye 
 No heterotropia or decompensated heterophoria (as 
assessed by cover test) 
 Free of ocular pathology 
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 Free of systemic pathology which may affect myopia progression 
 Able and willing to wear soft contact lenses for the duration of the trial 
 
Informed consent was obtained from the subjects after explanation of the nature and 
possible consequences of the study. 
 
Allocation of subjects to treatment group 
One experimenter, who allocated subjects to the treatment group, did not take part in 
any of the masked measurements, and was available to look at treatment regimens 
with vision training, and clinical issues relating to contact lens aftercare. Masked 
experimenters had no information about the way individual subjects were allocated 
to treatment groups, and remained masked for the duration of the study. 
 
Blocking variables were age, gender, and cylindrical refractive error and were 
stratified for spherical refractive error. All subjects wore contact lenses, either 
treatment or control, for the duration of the study.  
Subject numbers for each treatment group are shown in Table 1. There was no 
significant difference between treatment groups in age (p=0.26), baseline refraction 
(p=0.45) or gender (p=0.93) 
 
Table 1 here 
 
 
Treatment design 
(a) Altered spherical aberration  
Soft contact lenses were designed to alter ocular spherical aberration in addition to 
correcting the spherical equivalent axial refractive error. All measures of spherical 
aberration throughout the study were referenced to a 5mm diameter pupil. 
The front surface curvature was calculated using paraxial optics to correct the axial 
refractive error. The spherical aberration of the lens was manipulated by altering the 
eccentricity value of the front surface of the lens. The contact lenses were designed 
to alter the existing fourth order spherical aberration of the patient to -0.1 microns 
while maintaining the appropriate paraxial correction. Both the treatment and control 
group contact lenses were worn at least 10 hours per day. Compliance was 
assessed verbally by investigators at each follow up appointment. The contact 
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lenses were usually replaced every 6 months on average, in some cases deposits 
were noted at the first 3 months check in which case, lenses were replaced every 3 
months. Lenses were also replaced when a change of -0.25D or more was detected, 
or if lenses became damaged. Subjects were given a rub and rinse all in one solution 
to use. 
 
(b) Vision training 
The vision training regime consisted of lens flipper exercises37 using a +2.00D/-
2.00D flipper at 40cm. The exercises were performed for 18 minutes per day for up 
to six weeks. The subjects were instructed to wear their contact lenses during vision 
training and to complete a log book of their progress at the end of each training 
session. 
The training was conducted at home with the log books randomly checked for 
training compliance by an unmasked examiner. 
 
Procedures 
Details of these methods have been published previously 36, but are presented here 
in brief. 
 
Aberration measurement 
The monochromatic wavefront aberration function of the eyes without correction was 
measured using the Complete Ophthalmic Analysis System (COAS),38,39 at baseline, 
then with and without contact lenses at follow up visits. Aberration measurements 
obtained from 3 consecutive readings over a pupil diameter of 5mm were averaged.  
 
Subjective refraction 
Subjective refraction was performed to an accuracy of 0.12D before cycloplegia, to 
determine the paraxial power of the contact lens, the contact lenses were 
manufactured to an accuracy of 0.12D. 
 
Accommodation Function Assessment  
 
Accommodative response amplitudes were measured with an open field, infra-red 
Shin Nippon SRW 5000 auto-refractor.40,41  Measurements were obtained from the 
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left eye which was effectively occluded with an infra-red transmitting filter (Kodak 
Wratten 88A), whilst the right eye viewed the targets. 
 
At baseline the accommodative stimulus values were adjusted to take account of 
ocular accommodative demand as the subjects’ refractive errors were corrected with 
trial lenses.14 At all subsequent visits the subjects wore their contact lenses, with any 
over-refraction corrected with trial lenses, during measurement of accommodative 
function.  
 
(a) Monocular accommodative response amplitude to targets in real space. 
Targets were presented in real space at distances of 6.00m, 0.40m, 0.33m and 
0.25m. For 6.00m, the target consisted of a row of 6/7.5 Snellen letters. For the 
remaining distances, the target consisted of a block of words of N5 size type. The 
targets were presented in order of decreasing distance. 
 
(b) Accommodative convergence to accommodation response (AC/rA) 
ratio  
The subjective refraction of both eyes was placed in a trial frame for these 
measurements at baseline, and any over refraction placed over CAMS contact 
lenses at subsequent visits.  The Shin Nippon auto-refractor was used to measure 
the accommodative response amplitudes (from the left eye) while concurrent 
vergence measurements were taken using a near Howell-Dwyer phoria card, 
positioned at 0.33m. The procedure was repeated using the near Howell-Dwyer card 
with supplementary lenses of power +2.00D, +1.00D, -1.00D and -2.00D added 
binocularly to the subjective refraction. Since there is measurement error and 
resulting variability in both the accommodation and convergence tests when 
measuring the response AC/A ratio the slope of the principal axis was calculated. 
42,43 
(c) Monocular accommodative facility 
The accommodative facility was measured at 6.00m and 0.40m for the right eye only 
with semi-automated lens-flippers interfaced with a computer.  
Accommodative facility at 6m was measured using a Plano/–2.00D lens combination 
with the participant viewing 6/7.5 letters, while at 0.40m an N6 target was viewed 
through a flipper consisting of +2.00D/-2.00D lens combination. Distance 
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accommodative facility was measured before near facility. 
 
Cycloplegic auto-refraction 
Cycloplegic auto-refraction was used to determine change in refraction over the 
course of the trial. The refractive error of both eyes was determined following 
cycloplegia with two drops of Tropicamide Hydrochloride 1% (Minims; Chauvin) 44 
Objective measurement was made by an unmasked observer with a Nidek AR600-A 
auto-refractor using a series of five readings per eye.45  
 
Cycloplegic ocular biometry   
Ocular dimensions of both eyes were measured under cycloplegia using an IOL 
Master (Zeiss Humphrey, CA, USA). 
 
Statistical Methods 
Step 1 
An initial analysis of the data was performed using Partial Least Squares analysis 
(PLS). The reason for the PLS method is that in a situation with large numbers of 
variables with potential multicollinearity, in a relatively small sample size this analysis 
makes no assumptions about co-dependency and missing data46,47 and therefore 
produces the least biased view of any relationships between ocular parameters 
measured.  
PLS represents a multivariate analogue to multiple regression, where rather than 
examining a single y-variable against several x-variables, interest lies in the 
relationship between more than one y-variable (myopia progression for right and left 
eyes at different points in time) and several x-variables (remaining  29 measured 
variables at different points in time).  
For its first component, PLS looks for a linear combination of the y’s which has the 
highest correlation with a linear combination of the x’s, and the first component 
explains as much of the original variation as possible; the second component 
explains as much of the remaining variation as possible, and the process is repeated 
until no additional variation can be accounted for. This process identifies variables 
that are most strongly associated with myopia progression over the trial duration. 
Step 2 
In order to identify the role of treatment groups over time, a Repeated-Measures 
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Analysis of Variance (ANOVA) was then performed, modelling progression in the 
right eye against the design factors:  
1. Between subjects: Contact Lens (CL) group, Vision Training (VT) group and 
the interaction between CL and VT treatment. 
2. Within subjects: Visit, and interactions between Visit and the between-subject 
effects. 
 
Step 3 
Variables identified in step 1 were then introduced sequentially into the model as 
follows:  
1. Age effects: age of subject, and possible interaction between age and Contact 
Lens (CL) group; 
2. Interactions between age, ACA ratio, lag of accommodation, CL group and VT 
group;  
 
Step 4 
Significant interactions identified in earlier steps, were explored further in sub-groups 
(of the treatment groups) using t-tests.  
 
The PLS steps were performed using the SIMCA-P+11 statistical software; the, 
repeated-measures ANOVA and t-tests were performed using STATISTICA (version 
8). 
 
Results 
As reported by Allen et al 36, there was no significant effect of either treatment on 
myopia progression in the overall study population, with myopia progression of -
0.33D on average over the 2 years of the study. There was no significant treatment 
effect of either Vision Training or Contact Lens Spherical Aberration control on 
myopia progression. One hundred subjects completed the first 12 months of the trial, 
95 subjects completed the total 24 month trial period. Loss to follow up is reported in 
Allen et al. 36 Mean baseline refractive error was -2.93D, SD 1.73D, range -0.75 to -
8.02D.  
 
The other major findings are summarised below before a more detailed statistical 
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breakdown. 
1. Vision training had no effect on progression, although all treatment groups showed 
increased accommodative facility over the trial period. 
2. Altered spherical aberration by means of the contact lens treatment had the 
desired effect on lag of accommodation initially; however, effects were transient and 
had disappeared by the fifth visit at 12 months. 
3. Over the two years, there was no difference in progression between experimental 
and control groups, however a more detailed analysis by age showed a significant 
difference in treatment effect between contact lens treatment groups in younger 
subjects, aged under 16.9 years (median age) at baseline 
 
Change in spherical aberration as a result of contact lens treatment. 
Both the treatment and control contact lenses produced their desired effects and are 
shown in Figure 1. The mean spherical aberration in the treatment group changed 
from +0.05µm ± 0.04 without the lenses to -0.11µm ± 0.05 with the lenses in situ. 
This difference was significant at all visits (p< 0.001). The control contact lenses had 
no significant effect on the spherical aberration of the control group (+0.07µm ± 0.04 
without the lenses; +0.06µm±0.08 and with the lenses in situ; p=0.12). A repeated 
measures ANOVA showed no significant difference in spherical aberration of eye 
plus contact lens over the trial duration in either the CL treatment group (F (2.7, 
59.4)=0.95 p=0.42) or CL control group (F(3.2, 107.1) =0.92, p= 0.44).There was no 
significant difference in spherical aberration of the eye only over the duration of the 
trial (F (3.8,248.8)=1.47, p=0.21). 
 
Figure 1. here 
 
Step 1 Variables associated with myopia progression identified in the Partial Least 
Squares Analysis. 
 
29 variables, including refraction, biometry and accommodation variables, measured 
at visits over the 2 years of the study were modeled against right and left eye 
progression over the study duration. 
From the PLS results, numerically low values (indicating a negative, or more myopic 
shift in refractive error) for myopia progression, were most strongly associated with 
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high values for Visit (i.e. as more time passed there was a greater amount of myopia 
progression), AC/A ratio (a higher AC/A ratio was associated with a greater amount 
of myopia progression), lag of accommodation at all tested distances (increased lag 
of accommodation was associated with a greater amount of myopia progression) 
and low values for age (younger subjects experienced greater amounts of myopia 
progression). The PLS analysis produced the Loadings Plot shown in Figure 2, 
accounting for 38% of the total variation. The relative position of the x’s and y’s on 
the Loadings Plot reflect the closeness of the relationships between the original 
variables, with those grouped together (or diametrically opposite) on the plot 
indicating high positive (negative) association. 
As expected there was a high correlation between increase in axial length and 
increase in myopia progression (r= -0.68 p <0.001). Hence results in this paper link 
to change in refraction only. Biometry details can be found in Allen et al. 47 
 
Figure 2 here  
 
Step 2 Treatment group interactions 
A two-way repeated measures ANOVA was used to check for any interaction 
between treatment regimens and change in refraction in the right eye. There was no 
interaction between contact lens treatment and vision training treatment at either 12 
months (F (1,123) =0.03, p= 0.86) or 24 months (F (1,113) = 0.13 p = 0.72). Hence, it was 
possible to investigate the two treatment options separately. 
 
The repeated-measures ANOVA of myopia progression including only the design 
factors (Contact lens group, Vision Training group and Visit) highlighted significant 
differences between the overall means at each visit (F(3, 258)  = 24.76 p < 0.001), but 
no significance for the Contact Lens x Visit interaction (F(3, 258) = 2.25 p = 0.08).  
 
Step 3 Covariates  
The Variables Age, ACA ratio and Lag of accommodation identified in the PLS 
analysis were entered as covariates in the repeated measures ANOVA. 
Inclusion of age as a covariate indicated a significant overall effect on myopia 
progression due to subject age (F (1, 258) = 10.05 p < 0.001), but also that this effect 
differed between the CL treatment groups due to a significant interaction between CL 
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treatment group and age (F (1, 258) = 8.32 p = 0.01) 
 
AC/A ratio was the only other significant covariate (F (1, 252) = 6.07 p = 0.01). As AC/A 
ratio increased, myopia progression increased. Lag of accommodation was not 
significant in the model (p>0.10). 
 No other significant interactions were found between other covariates (lag of 
accommodation and AC/A ratio) and CL treatment group, or between any of the 
covariates and VT treatment group. 
 
Step 4 Further investigations of interactions 
The age/contact lens treatment interaction determined previously was examined in 
more detail. In order to keep the group populations as large as possible, with an 
equal number of subjects, the cohort was divided into two age groups based on a 
median split of age in years at baseline (younger than 16.9 years and 16.9 years and 
older).  
 
Figure 3 here 
 
Figure 3 shows that in younger subjects there appeared to be a contact lens 
treatment effect over the first 12 months of the trial that was not present in older 
subjects. After this, between 12 and 18 months there was then an increase in 
myopia progression in younger CL treatment subjects whose myopia progression 
reached a similar level to younger CL control subjects at 18 months. 
 
Due to the significant interaction between contact lens group and age group (F (1,95)= 
1.87, p=0.03) a two-way between-groups analysis of variance was conducted  to 
explore the impact of contact lens treatment and age on change of refraction. At 12 
months younger subjects in the CL treatment group had a significantly smaller 
change in refraction (-0.11± 0.29) than those in the contact lens control group (-
0.35±0.31; p= 0.01). In older subjects the difference between contact lens treatment 
group (-0.16± 0.28) and contact lens control group (-0.05± 0.20; p= 0.17) was not 
significant. 
 
By 24 months there was no significant interaction effect between contact lens group 
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and age group (F(1,90) = 3.78, p = 0.25). The main effect for age (F(1, 90) = 4.43, p = 
0.04) was deemed not significant in this case. The main effect for contact lens group 
was also not significant (F (1, 109) = 0.27, p = 0.60). This result indicates that the 
significant treatment effect in younger subjects was not maintained over the second 
year of the trial. In younger subjects the CL treatment group change in refraction at 
24 months (-0.38 ± 0.39) was not significantly different from the contact lens control 
group (-0.4 ± 0.43; p = 0.68). In the older age group, although there was increased 
myopic change in refraction in the CL treatment (-0.31 ± 0.27), this was not 
significantly different from the CL control group (-0.19D ± 0.24; p = 0.13). 
  
In an attempt to explain the significant treatment effect noted in younger subjects, 
variables associated with myopic progression in the preliminary PLS analysis (Step 
1) were investigated further. 
 
a) Lag of accommodation 
There was no significant difference in lag of accommodation at baseline between 
younger and older subjects (p=0.09). 
There was a significant reduction in lag of accommodation in the CL treatment group 
at 3 months (p=0.001).35 When split by median age group the reduction in lag of 
accommodation at 3 months was significant in younger CL treatment subjects (0.39 
± 0.68; p= 0.03), but not in older CL treatment subjects (0.28± 0.98; p= 0.14) 
subjects. The measured lag of accommodation at each visit is plotted in Figure 4. 
 
Figure 4 here  
 
Figure 4 demonstrates the initial successful reduction in lag of accommodation from 
baseline by the CL treatment at 3 months. However after this time point there is an 
increase in lag of accommodation over the duration of the trial.  
 
b) AC/A ratio  
Inclusion of additional measurements highlighted accommodative convergence to 
accommodation ratio (AC/A) as the only other significant covariate (p= 0.01). No 
further improvement to the model was achieved by including the interactions 
between these measurements and the CL group, or by the interactions between 
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these measurements and subject age. After Bonferroni correction there was no 
significant difference between AC/A ratios in CL and VT treatment groups at any visit 
during the trial.  No interaction was found between AC/A ratio and age, indicating a 
similar pattern of change in AC/A ratio in treatment groups over time in each age 
group. AC/A ratio in each CL and VT treatment group over the trial duration are 
reported in Table 2. 
 
Table 2 here  
In light of previous associations between treatment effects and near esophoria48,49 
we investigated the contact lens treatment effect in those with esophoria at near at 
baseline (n= 21).There was no significant difference in myopia progression between 
contact lens treatment groups at 12 months and 24 months (p= 0.47 and p= 0.54 
respectively) in subjects with near esophoria. 
 
Effect of Vision Training  
Facility of accommodation during the course of the trial was not significantly 
associated with myopia progression. Moreover there was no treatment effect of 
vision training on myopia progression. At 3 months there was a significant increase 
in near accommodative facility rate in the VT treatment group but not in the VT 
control group.35 Over the duration of the trial, facility of accommodation improved in 
both VT treatment and control groups (Table 3) by very similar amounts. There was 
no significant difference with regards to change in facility rate between VT treatment 
groups (distance or near) at 12 months or 24 months (p>0.09 in all cases). 
 
Although only near facility was trained, there was an increase in facility rate at both 
distance and near. Data for accommodative facility rates are presented in table 3 for 
subjects who attended baseline, 12 and 24 months visits.  
 
There was no interaction between accommodative facility change and age (p=0.69). 
Accommodative facility rate and facility training were not significantly associated with 
myopia progression. 
 
Table 3 here 
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Discussion 
The CAM study, which includes active interventions to alter accommodative lag and 
facility, shows that in a multifactorial model, AC/A ratio and lag of accommodation 
are significantly correlated to myopia progression confirming earlier observations by 
Mutti et al. 50 and Gwiazda et al.21  
 
The aim of the CL treatment was to reduce lag of accommodation, which has been 
implicated in previous work as a factor influencing myopia progression.15,16 Our 
results indeed show that CL treatment group had a reduction of lag of 
accommodation during the initial stages of treatment. This was especially 
pronounced in younger subjects.  
 
Lag of accommodation had increased at the end of the trial in CL treatment and CL 
control groups.  Despite the carefully controlled approach to accommodation 
measurement, it is possible that familiarization or repeated measurements of 
accommodation affected subject performance. A small increase in measured lag of 
accommodation was also noted over the duration of the STAMP trial,23 although not 
of the same magnitude as in this study. 
 
There was significantly less myopia progression with aberration control contact 
lenses in the younger half of our cohort over the first year of treatment; however 
progression increased in the second year of treatment, especially between 12 and 
18 months. The significant treatment effect at 12 months should be considered 
cautiously, as there was no significant difference in treatment groups prior to this 
point, possibly because of low myopia progression during this time.  
 
The regression after 12 months could be due to the lag of accommodation returning 
to pre-treatment levels.51 Inducing negative spherical aberration produces a 
sustained reduction in lag of accommodation for up to three months,34,35 but our 
results show that the effect wears off after approximately one year. Although 
adaptation effects may be a factor, there appears to be a general trend for lag of 
accommodation to increase in all groups over time. 
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Despite an initial reduction of accommodative lag in older subjects in the contact lens 
treatment group, they showed no reduction in myopia progression compared to the 
control group.   
 
The finding of a significant treatment effect in younger subjects has also been 
recently reported when using a novel spectacle lens design to reduce peripheral 
hyperopic defocus.25 Because younger subjects tended to show a greater 
progression rate than older subjects in this study, we can presume that they are 
more susceptible to myopigenic stimuli. Hence we can suggest that younger subjects 
respond better to reductions in myopigenic stimuli (such as the reduction in lag of 
accommodation induced by the treatment contact lenses in this study). 
Variations in pupil size may have altered the levels of spherical aberration which 
subjects experienced. Mean pupil diameter was 5.08mm (SD 0.83) which indicates 
that the actual spherical aberration would have been very close to desired levels. 
Subjects wearing the treatment contact lenses would experience -0.1 µm of fourth-
order spherical aberration referenced to a 5 mm diameter pupil, but this would vary 
from -0.04 µm to -0.2 µm for pupil diameters of 4mm to 6 mm. These values 
approximate to -0.55 and -1.23 D respectively of spherical aberration at the edge of 
the pupils,  so subjects would still experience negative spherical aberration 
compared to the control group.36 Since pupil size varies throughout the day the 
aberration correction provided by the contact lenses in the CL treatment group is 
unlikely to have remained consistent throughout the day, but it is expected that the 
subjects would still have experienced negative spherical aberration. 
 
Measuring accommodative lag through aspheric contact lenses could potentially 
affect the output of the autorefractor. However in the present study, measurements 
of accommodative lag were obtained by subtracting the resting state refraction from 
the refraction in the accommodated state. Since these measurements were both 
taken with the autorefractor through the same lens, the potential error in 
measurement from the aspheric contact lenses would be the same in all the 
accommodation measurements and be cancelled out by the calculation. We did not 
use our aberrometer to measure lag, as our instrument did not have an internal 
accommodative target; in addition lag of accommodation measurements with internal 
accommodative targets are often affected by proximal accommodation. 
17 
 
 
In an earlier study of correlations between accommodative functions and myopia 
progression in young adults, Allen and O’Leary16 found that lag of accommodation 
and accommodative facility were significantly correlated with the 12-month change in 
myopia. While the AC/A ratio was significantly correlated with progression in a single 
factor analysis, it did not correlate significantly with progression in Allen and 
O’Leary’s multifactorial model. Sample size, outliers or different age profiles might 
explain the differences in findings between the studies. 
 
In the present study, facility of accommodation was not significantly correlated with 
myopia progression through the course of the study. Facility of accommodation 
improved markedly from baseline in the vision training treatment group, however 
there was an almost equally large improvement in the facility of accommodation in 
the control group. Siderov 52 noted that even a few measurements of accommodative 
facility may improve facility rates, and it may be that our regular measurements of 
facility rate in controls were almost as effective at improving facility as was the full 
vision training regime. The present study shows that the improvements gained 
through training or repeated testing were sustained over the 6 months between 
visits, and over the 2 year trial period. There was no interaction of age with vision 
training effect, indicating that accommodative facility training is suitable for 
increasing accommodation dynamics in the range of ages in this study.  
 
It is noteworthy that the average rate of progression of myopia in this study was only 
-0.17D.y-1.Because of the increase in accommodative facility across all subjects we 
cannot rule out the possibility that an improvement in accommodative facility is 
effective in reducing rates of myopia progression. It remains possible that the 
improvement of facility in both treatment and control groups in the present study 
might be responsible for the lower progression rates of subjects. However the lack of 
a significant interaction between progression of myopia and accommodative facility 
in the statistical analysis makes this unlikely. Rather, it suggests that the relationship  
previously found between myopia progression and accommodative facility16 was not 
a causal one.  
 
Peripheral retinal blur has been indicated as a potential stimulus to myopia 
18 
 
progression.53,54 No difference between peripheral refraction profiles were found 
between treatment groups in an increased CAMS cohort including subjects with 
negative spherical aberration at baseline,55 suggesting that peripheral defocus was 
not a factor in progression differences seen between treatment groups in this study. 
 
In the younger subjects in this cohort we have seen a reduction in lag of 
accommodation prior to a reduction in myopia progression. This finding offers 
support to the hypothesis that if focusing errors at near are reduced this may have 
an impact on myopia progression for a limited period of time. 
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Figure 1. Spherical aberration of eye plus contact lens, in each CL treatment group 
and the cohort uncorrected (eye only) over the duration of the study. Error bars 
indicate standard error of the mean. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
25 
 
 
Figure 2. Loadings Plot from Partial Least Squares Analysis (NB- for clarity, only 
those effects which are significant are shown in the plot). Points clustered together 
are highly correlated. Points that fall on opposite sides of the origin exhibit negative 
correlations to one another 
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Figure 3. Younger and older CL and control groups change in refraction over the 2 
year trial period. * denotes a significant difference (p= 0.005) in myopia progression 
at 12 months between CL treatment and CL control in younger subjects (aged less 
than 16.9 years). Error bars indicate standard error of the mean. 
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Figure 4. Measured lag of accommodation at each visit for subjects split by age and 
CL treatment group. Error bars indicate standard error of mean. * indicates a 
significant difference in lag of accommodation between younger CL treatment group 
and younger CL control group (p=0.03) 
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Table 1 
Treatment groups, subject numbers and age ± 1 standard deviation at baseline. SE 
= Spherical equivalent 
 
altered spherical aberration 
and vision training 
(CL1+VT1) 
n=25 
mean age 16.72 ± 2.3 
mean SE -2.49D ±1.5 
 
vision training only 
 
(VT1) 
n=31 
mean age 17.39 ± 2.39 
mean SE -2.81D ± 1.81 
 
altered spherical aberration only 
 
(CL1) 
n=41 
mean age 16.29D ± 2.23 
mean SE -3.16 ± 1.68 
 
unaltered spherical aberration and 
no vision training 
(CL0+VT0) 
n=45 
mean age 16.69D ± 2.23 
mean SE -3.03 ± 1.84 
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Table 2 
AC/A ratio ± 1 standard deviation, average over the 2 year trial duration in subjects 
completing the trial. CL=Contact Lens VT=Vision Training. 
Treatment Group n AC/A Ratio ± 1SD 
CL Treatment + VT Treatment 
CL Treatment +VT Control 
16 
29 
4.44 ± 2.4 
4.17 ± 2.0 
CL Control +VT Treatment 20 4.53 ± 1.5 
CL  Control + VT Control 30 4.02 ± 1.33 
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Table 3  
Facility rates at distance and near for vision training (VT) treatment and control 
groups, over the duration of the trial. (1 VT control subject had missing facility rate 
data at 24 month visit). 
 
Visit Distance Facility rate (cpm) 
± 1 S.D. 
Near Facility rate (cpm) 
± 1 S.D. 
 VT Treatment VT Control VT Treatment VT Control 
Baseline 14.2 ± 5.3 
n=56 
12.9 ± 5.0 
n=86 
14.1 ± 4.0 13.7 ± 4.4 
12 months 18.8 ± 7.0 
n=38 
16.8 ± 5.2 
n=60 
16.9 ± 5.9 15.2 ± 5.5 
24 months 21.6 ± 6.2 
n=36 
18.9 ± 5.9 
n=58 
19.2 ± 5.9 18.0 ± 5.6 
 
 
 
 
